Healthcare and Life Science
Nxera Pharma appoints experienced commercial R&D executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan
Tokyo, Japan and Cambridge, UK – Nxera Pharma Co., Ltd. – formerly known as Sosei Group or Sosei Heptares – announces the appointment of Dr. Makoto Sugita, M.D., Ph.D., MBA, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (C...
ARU collaborates on new childhood cancer project
Scientists will work with Medannex to help accelerate treatment for bone cancer.
Jade Brennan joins Salus Wellness
Salus Wellness are happy to announce that Jade Brennan has joined Salus Wellness this month. Jade is a Permanent Makeup Artist specialising in services to create natural enhancements to the eyebrows, lips and eyes. ...
H.E.L Group introduces iso-BTC e to advance semiconductor technologies
New specialized isothermal calorimeter enables direct measurement of heat dissipation and optimization of thermal management and design ...
Celebrating the Cambridge Tech Week Innovation Alley Award winners
We’re delighted to share news and reactions from our Cambridge Tech Week Innovation Alley Award winners for ‘Start-Up of the Year’ and the ‘People’s Choice’ Awards. ...
Milton Keynes University Hospital purchases second Versius system to bring robotic MAS to more patients
CMR Surgical (CMR) – the global surgical robotics business – has today announced that Milton Keynes University Hospital NHS Foundation Trust (MKUH) have installed their second Versius Surgical Robotic System. ...
Nuclera strengthens team with three key appointments
Dr Gordon McInroy appointed as COO, Dr Tobias Ost as SVP Product Development, and Charu Maini as SVP of People ...
Inspiration, innovation, insights, impact, and collaboration – key takeaways from Cambridge Tech Week 2024
Cambridge Tech Week 2024 (CTW24), held from September 9 to 13, closed on a high, with young talents engaging with the dynamic Cambridge tech ecosystem, fuelling their tech aspirations. A whirlwind of a week, it was a global celebration of innovation and collaboration, with about 5,000 a...
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services ...
Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development
Next generation of industry-leading Cyto-Mine platform will offer new capabilities to optimize single-cell analysis workflow efficiency Opens up new, multiplexed assays and applications for antibody discovery and cell line development, and allows entry into new markets such as cell an...